Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

17.140
+0.2101.24%
Volume:2.79M
Turnover:47.74M
Market Cap:45.47B
PE:11.54
High:17.260
Open:16.780
Low:16.780
Close:16.930
52wk High:28.232
52wk Low:14.505
Shares:2.65B
HK Float Shares:535.00M
Volume Ratio:0.49
T/O Rate:0.52%
Dividend:0.45
Dividend Rate:2.63%
EPS(LYR):1.486
ROE:6.95%
ROA:1.40%
PB:0.80
PE(LYR):11.54
PS:0.91

Loading ...

FOSUN PHARMA Subsidiary's HLX3902 Injection Approved for Clinical Trials in Australia

Stock News
·
May 21

Sinopharm Group Stock Sheds 1.2% in Hong Kong

Dow Jones
·
May 21

Sinopharm Group Stock Falls 2.1% in Hong Kong

Dow Jones
·
May 18

FOSUN PHARMA's Strategic Move: $60 Million Secures Potential Over $2.5 Billion for AR1001

Stock News
·
May 14

Fosun Pharma Secures $60 Million Option for Alzheimer's Drug

MT Newswires Live
·
May 14

China's AI Power Consumption Set to Soar, Spotlight on Computing-Power Synergy

Stock News
·
May 14

Fosun Pharma's Unit's Registration Application for Blood Stasis Syndrome Drug Accepted in China

MT Newswires Live
·
May 13

Fosun Pharma Subsidiary’s Tao Hong Si Wu Tang Granules Secures NMPA Filing Acceptance

Bulletin Express
·
May 13

FOSUN PHARMA's Application for Traditional Chinese Medicine New Drug Accepted for Review

Stock News
·
May 13

Shanghai Fosun Pharma - Drug Registration Applications of Tao Hong Si Wu Tang Granules by Unit Accepted by Nmpa China

THOMSON REUTERS
·
May 13

Fosun Pharma Releases 2026 AGM & Second H-Shareholders Meeting Circular; Offers Digital Access and Print Options

Bulletin Express
·
May 11

Fosun Pharma Calls 16 June 2026 H Shareholders Meeting to Seek 10% Dual-Class Buyback Mandates

Bulletin Express
·
May 11

Fosun Pharma Calls 16 June AGM to Vote on RMB0.39 Dividend, RMB35 Billion Guarantee Cap and New Financing Mandates

Bulletin Express
·
May 11

Fosun Pharma's Unit Gets Nod for Registration of Venlafaxine Hydrochloride Tablets

MT Newswires Live
·
May 11

Henlius Biotech Gets European Commission's Nod for Hetronifly

MT Newswires Live
·
May 11

FOSUN PHARMA's Biosimilar HLX05-N Receives FDA Clearance for US Clinical Trial

Stock News
·
May 10

Fosun Pharma Subsidiary Obtains NMPA Green Light for Venlafaxine Sustained-Release Tablets

Bulletin Express
·
May 08

FOSUN PHARMA's Venlafaxine Hydrochloride Extended-Release Tablets Receive Market Approval

Stock News
·
May 08

Shanghai Fosun Pharma - Drug Registration Application for Venlafaxine Hydrochloride Sustained-Release Tablets Approved by China's Nmpa

THOMSON REUTERS
·
May 08

Sinopharm Group Stock Sheds 1.6% in Hong Kong

Dow Jones
·
May 08